Cytomegalovirus infection in the acquired immune deficiency syndrome.
CMV disease is a major problem in AIDS, though with a different profile from that seen in other immunosuppressed patients. The novel treatments, ganciclovir and phosphonoformate, have a major role in the management of such infections, but maintenance therapy is often required. Optimal maintenance regimens have yet to be established, especially where zidovudine is also being used.
Pinching
A J
AJ
Department of Immunology, St Mary's Hospital Medical School, London, UK.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000212:Acyclovir / Q000031:analogs & derivatives / Q000627:therapeutic use; D000224:Addison Disease / Q000175:diagnosis / Q000209:etiology; D000998:Antiviral Agents / Q000627:therapeutic use; D003092:Colitis / Q000175:diagnosis / Q000209:etiology; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000188:drug therapy; D004660:Encephalitis / Q000209:etiology; D004935:Esophageal Diseases / Q000209:etiology; D017245:Foscarnet; D015774:Ganciclovir; D006801:Humans; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D011024:Pneumonia, Viral / Q000175:diagnosis / Q000209:etiology; D012173:Retinitis / Q000209:etiology
D000998:Antiviral Agents; D017245:Foscarnet; D010746:Phosphonoacetic Acid; D015774:Ganciclovir; D000212:Acyclovir